Adeno-Associated Virus-Based Gene Therapy for Inherited Disorders

被引：0
作者：
Terence R Flotte
机构：
[1] University of Florida,Department of Pediatrics
来源：
Pediatric Research | 2005年 / 58卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Adeno-associated virus vectors are capable of long-term gene transfer without obvious adverse effects in a number of animal models. Over the last two decades, preclinical and early phase clinical trials in cystic fibrosis and alpha-1 antitrypsin deficiency were undertaken to test the feasibility of this approach. The results of those studies have been important since they have indicated that in vivo gene transfer is feasible and relatively safe. In addition, a number of key limitations to the current generation of AAV2 gene therapy vectors have been defined. The information about these limitations has been used to develop newer AAV vector approaches, based on new mutant and alternative serotype capsids and enhanced promoter systems. The evaluation of safety and efficacy of these newer agents is ongoing.
引用
收藏
页码：1143 / 1147
页数：4
相关论文
共 298 条
[1]  
Flotte T(1996)A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease Hum Gene Ther 7 1145-1159
[2]  
Carter B(1998)Adeno-associated virus vectors for gene therapy of cystic fibrosis Methods Enzymol 292 717-732
[3]  
Conrad C(1198)A phase I/II study of tgAAV-CF for the treatment of chronic sinusitis in patients with cystic fibrosis Hum Gene Ther 9 889-909
[4]  
Guggino W(1999)Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus Laryngoscope 109 266-274
[5]  
Reynolds T(2003)Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study Hum Gene Ther 14 1079-1088
[6]  
Rosenstein B(2002)A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies Hum Gene Ther 13 1349-1359
[7]  
Taylor G(2004)Phase I trial of intramuscular injection of a recombinant adeno-associated virus alpha 1-antitrypsin (rAAV2-CB-hAAT) gene vector to AAT-deficient adults Hum Gene Ther 15 93-128
[8]  
Walden S(2004)Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial Chest 125 509-521
[9]  
Wetzel R(2002)Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy Proc Natl Acad Sci U S A 99 11854-11589
[10]  
Flotte TR(2004)Clades of Adeno-associated viruses are widely disseminated in human tissues J Virol 78 6381-6388
12345678910